Medifast, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-18.7M | $2.1M | $99.4M | $143.6M | $164.0M | $102.9M | $77.9M | $55.8M |
| Depreciation & Amortization | $14.2M | $12.7M | $13.1M | $11.0M | $6.8M | $4.3M | $4.6M | $4.4M |
| Depreciation | $10.5M | $17.4M | $10.0M | $7.9M | $5.7M | $4.1M | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $7.6M | $7.4M | $8.2M | $11.1M | $9.9M | $6.8M | $4.5M | $3.1M |
| Net Cash from Operating Activities | $6.9M | $24.5M | $147.7M | $194.6M | $94.5M | $145.2M | $84.3M | $60.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $5.6M | $7.5M | $6.5M | $16.7M | $34.2M | $5.9M | $10.1M | $4.9M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-7.9M | $-26.5M | $-61.0M | $-11.4M | $-29.1M | $-1.3M | $-6.3M | $-1.2M |
| Financing Activities | ||||||||
| Dividends Paid | $195.0K | $715.0K | $73.0M | $71.6M | $63.9M | $53.2M | $35.4M | $23.2M |
| Stock Repurchases | $0 | $0 | $3.6M | $126.4M | $56.0M | $5.0M | $33.1M | $30.0M |
| Net Cash from Financing Activities | $-564.0K | $-1.5M | $-79.8M | $-199.6M | $-125.1M | $-57.1M | $-82.3M | $-53.3M |
| Net Change in Cash | $-1.6M | $-3.5M | $6.7M | $-16.5M | $-59.5M | $86.7M | $-4.4M | $6.3M |
| Free Cash Flow | $1.2M | $17.0M | $141.2M | $177.9M | $60.3M | $139.3M | $74.2M | $55.9M |